Centessa Pharmaceuticals plc Income Statement

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -7.28M6.85M-10.09M
Gross Profit -7.28M6.85M-10.09M
Operating items
Amortization - Intangibles 0.12M0.31M
Research & Development 4.26M9.30M95.66M155.08M124.41M150.24M
Selling, General & Administrative 0.79M1.14M42.89M55.20M53.73M50.81M
Operating Expenses 5.05M10.44M138.55M210.28M178.14M201.06M
Operating Income -5.05M-10.44M-374.08M-212.26M-171.28M-201.06M
EBIT -5.05M-10.44M-374.08M-212.26M-171.28M-201.06M
Non-operating items
Interest & Investment Income 0.01M-0.07M-1.17M0.24M10.48M14.02M
Other Non Operating Income 0.10M0.15M-4.37M2.34M-5.43M-34.10M
Non Operating Income 0.10M0.15M-4.37M2.34M-5.43M-1.69M
Net income details
EBT -5.06M-10.66M-380.96M-216.95M-176.14M-232.91M
Tax Provisions 0.11M-0.75M-25.06M2.84M
Profit After Tax -5.06M-10.66M-381.07M-216.21M-151.09M-235.76M
Income from Continuing Operations -5.06M-10.66M-381.07M-216.21M-151.09M-235.76M
Consolidated Net Income -5.06M-10.66M-381.07M-216.21M-151.09M-235.76M
Income towards Parent Company -5.06M-10.66M-381.07M-216.21M-151.09M-235.76M
Net Income towards Common Stockholders -5.06M-10.66M-381.07M-216.21M-151.09M-235.76M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 85.92M94.02M94.60M97.63M133.18M
Shares Outstanding (Diluted Average) 93.40M96.18M114.47M
EBITDA -4.65M-10.90M-380.29M-218.39M-148.09M-233.04M
Tax Rate 0.34%14.22%